Dec 9 (Reuters) - CVS Health (CVS) on Tuesday forecast 2026 profit above Wall Street estimates and this year's projected earnings, signalling steady progress in the health conglomerate's turnaround plan.
CVS stock rose 5% in early trading on Tuesday.
The company in October projected double-digit earnings growth for 2026 after raising its 2025 profit forecast for the third time.
"We are closing out 2025 with meaningful momentum across our businesses and we expect another year of strong earnings growth in 2026," said Chief Financial Officer Brian Newman on Tuesday.
The company forecast 2026 adjusted profit to be in the range of $7.00 to $7.20 per share, compared with analysts' average estimate of $7.16, according to data compiled by LSEG.
It, however, expects total revenue of at least $400 billion next year, below analysts' average estimate of $419.26 billion.
CVS also raised its 2025 adjusted profit forecast to $6.60 to $6.70 per share from $6.55 to $6.65 previously.
(Reporting by Sneha S K in Bengaluru; Editing by Shinjini Ganguli)
LATEST POSTS
- 1
Canada cancels its 1st moon rover: 'It's hopefully not a lost cause' - 2More charges filed against ex-left-wing RAF member Daniela Klette
- 3Taco Bell debuts its Baja Blast pie, and the reactions may surprise you
- 4IDF continues counterterrorism operations in Gaza Strip, including destroying terror tunnels
- 56 Popular Ladies' Aromas On the planet
- 3D Printers for Specialists
- The Fate of Rest: Patterns in Shrewd Beds
- A quick recap of 'Stranger Things' Seasons 1-4, plus key episodes to rewatch before Volume 1 of the final season drops
- How to disinfect if the stomach bug hits your home
- From Loner to Force to be reckoned with: Individual Accounts of Change
- San Francisco mayor says city in talks to bring pandas back to zoo ahead of trip to Asia
- This professional Santa's dream of spreading holiday cheer fuels stroke recovery
- Energy security rifts widen in Europe
- Best Disney Palace: Which One Catches Your Creative mind?
